Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive
Sponsored by Universidad Autonoma de Madrid
About this trial
Last updated 4 years ago
Study ID
PI-4321
Status
Completed
Type
Observational
Placebo
No
Accepting
12 to 99 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 5 years ago
What is this trial about?
The presence of the described silent hypoxia in subjects diagnosed with COVID19 highlights
the need for valid tools to assess respiratory capacity. The Roth test has been associated
with acceptable sensitivity and specificity criteria in patients with previous respiratory
pathology; however, its validity in this type of patient has not been proven.
What are the participation requirements?
Inclusion Criteria
1. having been diagnosed as COVID-19 positive and with symptoms compatible with Sars-Cov-2 infection in the last 7 days prior to assessment,
2. having an understanding of Spanish,
3. and having no history of respiratory pathology prior to the current infection.